INTRODUCTION
Human mesenchymal stem cells (hMSCs) show promise in the field of regenerative medicine because they can modulate numerous incurable diseases. Mesenchymal stem cells, also called mesenchymal stromal cells, are a type of adult stem cell, that play a role in maintaining and repairing various adult tissues and organs (Pittenger et al., 1999) .
hMSCs have emerged as a promising candidate for the cell-based therapy of various diseases, such as cardiovascular diseases (Faiella & Atoui, 2016) , diabetic nephropathy (Liu & Tang, 2016) , and diverse brain injuries including stroke, neural trauma, and heatstroke (Hsuan et al, 2016) .
MSCs are non-hematopoietic, multipotent cells that are present in adult marrow. They are capable of self-renewal and multilineal differentiation into various tissues of mesodermal origin, such as bone, cartilage, tendon, fat, heart, muscle, and marrow stroma (Pittenger et al., 1999) ; (Deans & Moseley, 2000) . hMSCs show several superior properties for therapeutic use compared to other types of stem cells. For successful cell-based therapies with hMSCs, a substantial number of cells are needed, requiring extensive ex vivo cell expansion. Owing to prolonged ex vivo expansion needed in the clinic to obtain a sufficient number of cells for therapy, long-term culture will likely evoke continuous changes in hMSCs, including cellular senescence (Yang et al., 2012) ; (Park et al., 2005) . Considering the strengths and weaknesses of hMSCs in ex vivo cultures would provide us with some novel approaches for overcoming limitations to their therapeutic efficacy and maximize their clinical value.
Advantages of MSCs over Other Stem Cell Types in Clinical Applications
Among various stem cell types, hMSCs show several superior properties for clinical use in cell-based therapies.
The benefits and limitations of each stem cell type are discussed and summarized in Table 1 .
Embryonic stem cells (ESCs) are produced in the inner cell mass of the blastocyst during mammalian embryonic development, late in the first week after fertilization (Evans & Kaufman, 1981) ; (Boyle et al., 2006 Lin28 (Takahashi & Yamanaka, 2006) ; (Takahashi et al., 2007) ; (Zhang et al., 2016 various types of cells (Tian et al., 2015) ; (Xia et al., 2013) ; (Carpenter et al., 2012) . Even though iPSCs are attractive candidates for cell-based therapy, their use is limited by the associated risk of teratoma formation after transplantation, which is also a concern in ESC applications. Genomic instabilities and epigenetic variations of iPSs, such as aneuploidy (Amps et al., 2011) (Crisan et al., 2008) ; (Turinetto et al., 2016) .
Upon isolation, hMSCs are characterized by their ability to adhere to the surface of plastic plates and fibroblast-like morphology. Their overall isolation procedure is relatively simple compared to that for other types of stem cells (Pittenger et al., 1999) . Isolated and expanded ex vivo cells can be differentiated into osteocytes, chondrocytes, adipocytes, myocytes, and marrow stroma (Pittenger & Martin, 2004) .
Another characteristics of hMSCs that contributes to their therapeutic effect is that they secrete various soluble growth factors and cytokines that act in endocrine and paracrine fashions, in turn affecting their therapeutic effect (Monsel et al., 2015) . MSCs have limited ability to proliferate in cultures. Senescence activations were observed in hMSCs from different sources, such as bone marrow (Park et al., 2005) ; (Minieri et al, 2015) , dental pulp (Muthna et al., 2010) , reported that the osteogenic activity of hMSCs were reduced according to their ex vivo culture (Banfi et al., 2000) .
On the other hand, the osteogenic potential of senescent hMSCs remained the same or even increased in some studies (Wagner et al., 2008) ; (Bruder et al., 1997) ; (Digirolamo et al., 1999) . Some studies reported that senescent hMSCs reveal the impaired balance between osteogenic differentiation to the osteogenic versus adipogenic lineages (Kim et al., 2012) .
The altered immunoregulatory activities of hMSCs during cellular senescence also influence the therapeutic potentials of cells (Sepulveda et al., 2014) . Studies related to the altered immunomodulatory functions of senescent hMSCs strongly support the idea that in vivo administration of senescent hMSCs could evoke an inflammatory response at a systemic level and lead to sepsis (Turinetto et al., 2016) .
Proper cell migration toward relevant stimuli is also an essential factor for the functional engraftment of hMSCs into diseased loci. Another study demonstrated altered cell migration due to changes in MSC surface markers during prolonged cultivation, which can diminish the homing ability of hMSCs (Jung et al., 2011) .
Despite arrested growth upon senescence being a potent tumor suppressor mechanism, which can protect hMSCs from malignant transformation after transplantation, paradoxically, senescence itself can affect the paracrine factors secreted from cells to evoke the tumor-promoting function (Liu et al., 2007) . These studies suggest that the senes- 
